Lunai Bioworks Inc (LNAI) Stock Price, Quote & News

Company Profile

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 918 1980

Website: www.lunaibioworks.com

Address:

2080 Century Park East, Suite 906, Los Angeles, United States

MarketForecasting May. 15 at 12:01 PM

$LNAI Nasdaq should move to delist this garbage immediately, they are non compliant in two categories . It is a mockery to the other companies who work day and night to stay listed through tangible businesses . This company is a parasitic leach , who has an accumulated deficit of nearly 1 billion dollars , from what ???

0 · Reply

102da1 May. 15 at 1:14 AM

$LNAI so many dummie shareholders in this stock

0 · Reply

MarketForecasting May. 14 at 8:00 PM

$LNAI reverse split announced tomorrow ah , Nasdaq should delist this trash immediately and not grant them a cheap way to get compliant , delist this trash .

1 · Reply

Stengaard1 May. 13 at 10:07 PM

$LNAI last week shareholders meeting gives Management the right to make a reverse split between 1/3 and 1/30. https://ir.lunaibioworks.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=19440802

2 · Reply

TCLutz May. 13 at 4:42 PM

$EZGO $HAO $KRKR $LNAI $POM Gamble…

0 · Reply

only1mc May. 13 at 4:41 PM

$WOK 144 million traded. and climbing.. Im sure hedges don't want a lawsuit like $LNAI . .. no more shares left. 🚀 squeeze em

1 · Reply

MACnTEEZ May. 13 at 3:43 PM

$LNAI gapper soon

0 · Reply

matthewboyntonbeach May. 13 at 2:35 PM

$LNAI Blackrock owns 127,314 shares, if they start loading up more shares we going wayyyyy higher

0 · Reply

NetworkNewsWire May. 13 at 1:19 PM

CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research $OTLC $AMGN $JNJ $ABBV $LNAI https://ibn.fm/v9RPJ

0 · Reply

matthewboyntonbeach May. 13 at 3:19 AM

$LNAI do something stupid tomorrow please, like open above $1.50

1 · Reply

Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against ‘John Doe' ‘Naked' Short-Sellers of Lunai Common Stock

May 4, 2026, 9:35 AM EDT - 11 days ago

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP

Apr 15, 2026, 9:10 AM EDT - 4 weeks ago

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships

Apr 7, 2026, 9:05 AM EDT - 5 weeks ago

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

2026-03-26T12:55:26.000Z - 7 weeks ago

Lunai Bioworks acquires BBB delivery platform in Alzheimer’s for $20M

Mar 26, 2026, 8:50 AM EDT - 7 weeks ago

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications

2026-03-19T14:10:31.000Z - 2 months ago

Lunai Bioworks announces formation of Pathfinder Consortium

Mar 19, 2026, 9:57 AM EDT - 2 months ago

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

2026-03-17T12:29:40.000Z - 2 months ago

Why Is Lunai Bioworks Stock (LNAI) Rallying Today?

2026-02-19T13:47:50.000Z - 3 months ago

Lunai Bioworks granted U.S. patent for AI drug discovery system

Feb 19, 2026, 8:30 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Locks Down Core AI Architecture with U.S. Patent Enabling Precision Disease Subtyping

Feb 13, 2026, 8:31 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

2026-02-09T16:25:07.000Z - 3 months ago

Lunai Bioworks CEO says established three ‘scalable revenue generating engines’

2026-02-09T14:20:50.000Z - 3 months ago

Lunai Bioworks announces oncology collaboration with a clinical-stage partner

Feb 9, 2026, 9:15 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Launches AI Oncology Pilot with Clinical-Stage Partner to Analyze Randomized Phase 2 Metastatic Colorectal Cancer Survival Trial Data

Jan 27, 2026, 10:36 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Launches Sentinel, an AI Safeguard to Block Large Language Models from Generating Novel Chemical Weapons

2026-01-26T14:35:53.000Z - 3 months ago

Lunai Bioworks expands AI program into commercial AUD drug discovery

Jan 26, 2026, 9:30 AM EST - 3 months ago

Lunai Bioworks (NASDAQ: LNAI) Expands NIH-Funded AI Program into Commercial Alcohol Use Disorder Drug Discovery

Dec 18, 2025, 9:00 AM EST - 5 months ago

Lunai Bioworks (NASDAQ: LNAI) Featured in International Business Times as AI Partnership Talks Advance

Dec 9, 2025, 7:45 AM EST - 5 months ago

Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market

2025-11-25T12:55:12.000Z - 6 months ago

Lunai Bioworks’ immune cell therapy shows tumor regression, wins first license

Nov 25, 2025, 7:45 AM EST - 6 months ago

Lunai Bioworks Secures First Licensing LOI Following Landmark Breakthrough Showing Complete Tumor Regression in Humanized Cancer Models

2025-11-05T14:34:03.000Z - 6 months ago

Lunai Bioworks announces regression of tumors with immune cell therapy

Nov 5, 2025, 9:22 AM EST - 6 months ago

Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy

2025-10-30T13:41:27.000Z - 7 months ago

Lunai Bioworks announces early results from AI-based platform

Oct 30, 2025, 9:32 AM EDT - 7 months ago

Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds

Oct 16, 2025, 9:45 AM EDT - 7 months ago

Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics

2025-10-16T13:30:37.000Z - 7 months ago

Lunai Bioworks regains compliance with Nasdaq minimum bid price rule

Oct 16, 2025, 9:15 AM EDT - 7 months ago

Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement

Oct 6, 2025, 9:15 AM EDT - 7 months ago

Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline

Sep 30, 2025, 9:15 AM EDT - 8 months ago

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense

Sep 25, 2025, 8:30 AM EDT - 8 months ago

Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships

Sep 24, 2025, 4:50 PM EDT - 8 months ago

Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split

Sep 11, 2025, 7:00 AM EDT - 8 months ago

Lunai Bioworks subsidiary BioSymetrics and Brigham and Women's Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics

Sep 9, 2025, 8:47 AM EDT - 8 months ago

Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery

Sep 8, 2025, 8:50 AM EDT - 8 months ago

Lunai Bioworks Strengthens European Strategy Through Restructuring

Sep 4, 2025, 10:05 AM EDT - 9 months ago

Lunai Bioworks Inc. Retains American Defense International

Aug 27, 2025, 9:45 AM EDT - 9 months ago

Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics

Aug 8, 2025, 10:45 AM EDT - 9 months ago

Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks

Jul 28, 2025, 10:38 AM EDT - 10 months ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 17, 2025, 9:15 AM EDT - 10 months ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 9, 2025, 8:00 AM EDT - 11 months ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jun 30, 2025, 9:21 AM EDT - 11 months ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 3, 2025, 9:15 AM EDT - 1 year ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

May 22, 2025, 3:12 PM EDT - 1 year ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 1 year ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 14, 2025, 9:15 AM EDT - 1 year ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 13, 2025, 9:15 AM EDT - 1 year ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Apr 22, 2025, 9:20 AM EDT - 1 year ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 9, 2025, 9:25 AM EDT - 1 year ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 4, 2025, 9:40 AM EDT - 1 year ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 1 year ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Feb 26, 2025, 1:25 PM EST - 1 year ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 9:15 AM EST - 1 year ago

Renovaro Announces $15 million in Equity Committed

Jan 7, 2025, 6:51 PM EST - 1 year ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

AGPU

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 1 year ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 6, 2025, 9:15 AM EST - 1 year ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Dec 30, 2024, 9:00 AM EST - 1 year ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 23, 2024, 9:00 AM EST - 1 year ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 20, 2024, 3:40 PM EST - 1 year ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

MarketForecasting May. 15 at 12:01 PM

0 · Reply

102da1 May. 15 at 1:14 AM

$LNAI so many dummie shareholders in this stock

0 · Reply

MarketForecasting May. 14 at 8:00 PM

$LNAI reverse split announced tomorrow ah , Nasdaq should delist this trash immediately and not grant them a cheap way to get compliant , delist this trash .

1 · Reply

Stengaard1 May. 13 at 10:07 PM

2 · Reply

TCLutz May. 13 at 4:42 PM

$EZGO $HAO $KRKR $LNAI $POM Gamble…

0 · Reply

only1mc May. 13 at 4:41 PM

$WOK 144 million traded. and climbing.. Im sure hedges don't want a lawsuit like $LNAI . .. no more shares left. 🚀 squeeze em

1 · Reply

MACnTEEZ May. 13 at 3:43 PM

$LNAI gapper soon

0 · Reply

matthewboyntonbeach May. 13 at 2:35 PM

$LNAI Blackrock owns 127,314 shares, if they start loading up more shares we going wayyyyy higher

0 · Reply

NetworkNewsWire May. 13 at 1:19 PM

CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research $OTLC $AMGN $JNJ $ABBV $LNAI https://ibn.fm/v9RPJ

0 · Reply

matthewboyntonbeach May. 13 at 3:19 AM

$LNAI do something stupid tomorrow please, like open above $1.50

1 · Reply

MACnTEEZ May. 12 at 11:58 PM

$LNAI people didnt digest or see the news, this will gap soon, ill give it few days!

0 · Reply

TCLutz May. 12 at 9:05 PM

$HAO <— $AIXI $LNAI $NVDA $SPY THE QUEEN HAS SPOKEN!! 🫡💪

0 · Reply

TCLutz May. 12 at 9:00 PM

$HAO <— $AIXI $LNAI $NVDA $SPY LOWEST PRICED + EXTREMELY OVERSOLD AI PLAY ON THE ENTIRE MARKET Offering closes today. Raised a measly $6.5m… Should rebound HARD to .25 or better!! 💪🫡🔥

0 · Reply

NetworkNewsWire May. 12 at 7:21 PM

InvestorNewsBreaks – $LNAI Targets Alleged Naked Short Sellers in Securities Fraud Lawsuit https://ibn.fm/xlRH8

0 · Reply

JuanValdex May. 12 at 1:14 PM

$LNAI $BFRG ,, WE KNEW THIS HAPPENED J-6.. WHERE WERE YA CORE IR? but seriously you pussies ... maybe we the market will realize there is more space for him at the lunai board and he can do a stock swap 2/1 by selling bfrg and buying lunai . it seems like a good tax move FOR HIM.

0 · Reply

Porto98 May. 12 at 1:14 PM

$LNAI

0 · Reply

only1mc May. 12 at 12:46 PM

$CREG unnatural naked shorting right there. they are not good enough to win without that card in their back pocket. $LNAI is taking them to court. i hope its way more then a slap on the wrist. sec allows it. Crazy game we play. with an imaginary ball

2 · Reply

Kevkm1989 May. 12 at 11:24 AM

$LNAI not only are shorts screwed they are going to jail https://www.globenewswire.com/news-release/2026/05/12/3292467/0/en/dickinson-wright-and-fox-rothschild-join-forces-to-file-lawsuit-against-john-doe-naked-short-sellers-of-lunai-common-stock.html

3 · Reply

DC351988 May. 12 at 10:48 AM

$LNAI Lunai Bioworks Files Delaware Federal Lawsuit Against Naked Short-Sellers Who Traded ~554M Shares On March 17, 2026, Representing 15.3 Times Company's Total Outstanding Shares 05/12/26 2:08 AM

0 · Reply

TCLutz May. 12 at 12:32 AM

$HAO Overnight always gives me false hope… Do it for us one time! Lol Let’s see a recovery to ~.15 😈 $POM $LNAI $KRKR $EZGO

0 · Reply

Stengaard1 May. 11 at 9:56 PM

$LNAI $LNAI at the stockholder meeting on May the 8th the shareholders gave the board permission to make a reverse split in order to regain compliance with the 1 dollar rule - the jury is still out as to whether or not this will satisfy Nasdaq https://ir.lunaibioworks.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=19432192

2 · Reply

TCLutz May. 11 at 8:09 PM

$HAO Directions not clear… slammed fingers in door… barely missed my nutsack on that one! 🤣 $KRKR $POM $EZGO $LNAI

1 · Reply

Market Cap	7.18M
Revenue (ttm)	0.00
Net Income (ttm)	-178.01M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	1,009,200
Avg Vol	26,704,340
Day's Range	N/A - N/A
Shares Out	24.19M
Stochastic %K	12%
Beta	0.34
Analysts	Strong Buy
Price Target	N/A